✦ LIBER ✦

BRAF mutations in papillary carcinomas of the thyroid

✍ Scribed by Fukushima, Toshihiko; Suzuki, Shinichi; Mashiko, Miyuki; Ohtake, Tohru; Endo, Yoshiyuki; Takebayashi, Yuji; Sekikawa, Koji; Hagiwara, Koichi; Takenoshita, Seiichi

Book ID: 110067830
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 128 KB
Volume: 22
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1206739

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinicopathologic significance of BRAF V

Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid : A meta-analysis

✍ Ju-Han Lee; Eung-Seok Lee; Young-Sik Kim 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 699 KB

## Abstract ## BACKGROUND. Numerous studies have investigated the clinical significance of __BRAF__ mutation in papillary thyroid carcinoma (PTC). However, there have been conflicting data on the usefulness of __BRAF__ mutation as a prognostic marker of PTC. To address this controversy, the freque

The presence of BRAF point mutation in a

The presence of BRAF point mutation in adult papillary thyroid carcinomas from atomic bomb survivors correlates with radiation dose

✍ Keiko Takahashi; Hidetaka Eguchi; Koji Arihiro; Reiko Ito; Kojiro Koyama; Midori 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 1 views

## Abstract In papillary thyroid carcinogenesis, the constitutively activated mitogen‐activated protein (MAP) kinase signaling pathway caused by a genetic alteration such as __RET__/__PTC__ rearrangement or mutation of __RAS__ and __BRAF__ genes, is thought to be a major early event. Among these, t

The BRAF mutation is useful for predicti

The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma

✍ Tae Yong Kim; Won Bae Kim; Yoon Soo Rhee; Ja Young Song; Jung Min Kim; Gyungyub 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Genotyping of an Italian papillary thyro

Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAFV599Ins)

✍ Claudio Carta; Sonia Moretti; Lucia Passeri; Flavia Barbi; Nicola Avenia; Antoni 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

RET rearrangements and BRAF mutation in

RET rearrangements and BRAF mutation in undifferentiated thyroid carcinomas having papillary carcinoma components

✍ Kunio Mochizuki; Tetsuo Kondo; Tadao Nakazawa; Masanori Iwashina; Tomonori Kawas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB

Detectable BRAF mutation in serum DNA sa

Detectable BRAF mutation in serum DNA samples from patients with papillary thyroid carcinomas

✍ Tony C. Y. Chuang; Alice Y. C. Chuang; Luana Poeta; Wayne M. Koch; Joseph A. Cal 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

## Abstract ## Background. An activating point mutation of the __BRAF__ oncogene results in a V600E amino acid missense mutation found in a majority of papillary thyroid carcinomas (PTC). ## Methods. In this study, 28 matched tumor and serum samples obtained from patients with both benign and ma